Obamacare has plenty of critics, but you won't find AmerisourceBergen among them. That's because the Pennsylvania-based drug distributor stands to be one of the plan's biggest beneficiaries. As millions of additional Americans gain access to health care, chances are their prescription drugs will be originated by Amerisource.
While revenues increased a modest 4% last year to $70 billion, by keeping operating expenses in check, net income more than doubled to $504 million. Pharmaceutical sales are expected to grow another 3% to 5% this year, much of it fueled by sales of new generic drugs to one of the biggest segments of the population -- aging Baby Boomers. --P.N.
